93 related articles for article (PubMed ID: 22381750)
1. [Fungal infection induced by Cryptococcus neoformans aerosol inhalation in immunosuppressed Balb/c mice].
Fu M; Wang Y; Lin Y; Zhang L; Luo W; Zhao T; Long M; Cao H
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):169-72. PubMed ID: 22381750
[TBL] [Abstract][Full Text] [Related]
2. Experimental systemic infection with Cryptococcus neoformans var. grubii and Cryptococcus gattii in normal and immunodeficient mice.
Capilla J; Maffei CM; Clemons KV; Sobel RA; Stevens DA
Med Mycol; 2006 Nov; 44(7):601-10. PubMed ID: 17071553
[TBL] [Abstract][Full Text] [Related]
3. Pathogenicity of basidiospores of Filobasidiella neoformans var. neoformans.
Sukroongreung S; Kitiniyom K; Nilakul C; Tantimavanich S
Med Mycol; 1998 Dec; 36(6):419-24. PubMed ID: 10206753
[TBL] [Abstract][Full Text] [Related]
4. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice.
Hoag KA; Street NE; Huffnagle GB; Lipscomb MF
Am J Respir Cell Mol Biol; 1995 Oct; 13(4):487-95. PubMed ID: 7546779
[TBL] [Abstract][Full Text] [Related]
5. Complementation of a capsule deficient Cryptococcus neoformans with CAP64 restores virulence in a murine lung infection.
Wilder JA; Olson GK; Chang YC; Kwon-Chung KJ; Lipscomb MF
Am J Respir Cell Mol Biol; 2002 Mar; 26(3):306-14. PubMed ID: 11867339
[TBL] [Abstract][Full Text] [Related]
6. Experimental murine pulmonary cryptococcosis. Differences in pulmonary inflammation and lymphocyte recruitment induced by two encapsulated strains of Cryptococcus neoformans.
Curtis JL; Huffnagle GB; Chen GH; Warnock ML; Gyetko MR; McDonald RA; Scott PJ; Toews GB
Lab Invest; 1994 Jul; 71(1):113-26. PubMed ID: 8041111
[TBL] [Abstract][Full Text] [Related]
7. Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans.
Huffnagle GB; Toews GB; Burdick MD; Boyd MB; McAllister KS; McDonald RA; Kunkel SL; Strieter RM
J Immunol; 1996 Nov; 157(10):4529-36. PubMed ID: 8906831
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of infection by the human fungal pathogen Cryptococcus neoformans.
Sabiiti W; May RC
Future Microbiol; 2012 Nov; 7(11):1297-313. PubMed ID: 23075448
[TBL] [Abstract][Full Text] [Related]
9. Cdk8 and Ssn801 Regulate Oxidative Stress Resistance and Virulence in Cryptococcus neoformans.
Chang AL; Kang Y; Doering TL
mBio; 2019 Feb; 10(1):. PubMed ID: 30755515
[No Abstract] [Full Text] [Related]
10. Naïve B cells reduce fungal dissemination in Cryptococcus neoformans infected Rag1
Dufaud C; Rivera J; Rohatgi S; Pirofski LA
Virulence; 2018 Jan; 9(1):173-184. PubMed ID: 28837391
[TBL] [Abstract][Full Text] [Related]
11. Persistence of infection in mice inoculated intranasally with Cryptococcus neoformans.
Anderson DA; Sagha HM
Mycopathologia; 1988 Dec; 104(3):163-9. PubMed ID: 3070384
[TBL] [Abstract][Full Text] [Related]
12. Effects of diethylstilbestrol and cyclophosphamide on the pathogenesis of experimental Cryptococcus neoformans infections.
Duke SS; Fromtling RA
Sabouraudia; 1984; 22(2):125-35. PubMed ID: 6374933
[TBL] [Abstract][Full Text] [Related]
13. Cell wall targeting of laccase of Cryptococcus neoformans during infection of mice.
Waterman SR; Hacham M; Panepinto J; Hu G; Shin S; Williamson PR
Infect Immun; 2007 Feb; 75(2):714-22. PubMed ID: 17101662
[TBL] [Abstract][Full Text] [Related]
14. Laccase expression in murine pulmonary Cryptococcus neoformans infection.
Garcia-Rivera J; Tucker SC; Feldmesser M; Williamson PR; Casadevall A
Infect Immun; 2005 May; 73(5):3124-7. PubMed ID: 15845520
[TBL] [Abstract][Full Text] [Related]
15. Fungemia during murine cryptococcosis sheds some light on pathophysiology.
Lortholary O; Improvisi L; Nicolas M; Provost F; Dupont B; Dromer F
Med Mycol; 1999 Jun; 37(3):169-74. PubMed ID: 10421848
[TBL] [Abstract][Full Text] [Related]
16. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
[TBL] [Abstract][Full Text] [Related]
17. Natural cellular resistance of beige mice against Cryptococcus neoformans.
Hidore MR; Murphy JW
J Immunol; 1986 Dec; 137(11):3624-31. PubMed ID: 3537121
[TBL] [Abstract][Full Text] [Related]
18. CD4+ T cell-dependent acquired state of immunity that protects the brain against Cryptococcus neoformans.
Hill JO; Aguirre KM
J Immunol; 1994 Mar; 152(5):2344-50. PubMed ID: 7907637
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of immunosuppression induced by different doses of cyclophosphamide in normal mice].
Qi L; Song Y; Wang W; Cui W; Zhang X; Liu Z; Sun N; Li N
Wei Sheng Yan Jiu; 2010 May; 39(3):313-5, 325. PubMed ID: 20568461
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans calcineurin A mutant strain.
Wormley FL; Cox GM; Perfect JR
Microb Pathog; 2005; 38(2-3):113-23. PubMed ID: 15748813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
